MediPal Corporation (MAHLY)
MediPal Statistics
Share Statistics
MediPal has 207.95M shares outstanding. The number of shares has increased by -0.98% in one year.
| Shares Outstanding | 207.95M |
| Shares Change (YoY) | -0.98% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 197.28M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 11.96 and the forward PE ratio is null. MediPal's PEG ratio is 2.01.
| PE Ratio | 11.96 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/FCF Ratio | 11.69 |
| PEG Ratio | 2.01 |
Enterprise Valuation
MediPal has an Enterprise Value (EV) of 267.48B.
| EV / Sales | 0.08 |
| EV / EBITDA | 4.1 |
| EV / EBIT | 4.33 |
| EV / FCF | 6.3 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.
| Current Ratio | 1.23 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | 5916.38 |
Financial Efficiency
Return on Equity is 6.91% and Return on Invested Capital is 4.14%.
| Return on Equity | 6.91% |
| Return on Assets | 2.31% |
| Return on Invested Capital | 4.14% |
| Revenue Per Employee | $272.18M |
| Profits Per Employee | $3.17M |
| Employee Count | 13,075 |
| Asset Turnover | 1.98 |
| Inventory Turnover | 19.25 |
Taxes
| Income Tax | 22.97B |
| Effective Tax Rate | 30.74% |
Stock Price Statistics
The stock price has increased by 7.42% in the last 52 weeks. The beta is 0.02, so MediPal's price volatility has been higher than the market average.
| Beta | 0.02 |
| 52-Week Price Change | 7.42% |
| 50-Day Moving Average | 15.38 |
| 200-Day Moving Average | 16.26 |
| Relative Strength Index (RSI) | 63.3 |
| Average Volume (20 Days) | 273 |
Income Statement
In the last 12 months, MediPal had revenue of 3,558.7B and earned 41.47B in profits. Earnings per share was 195.83.
| Revenue | 3,558.7B |
| Gross Profit | 246.66B |
| Operating Income | 47.33B |
| Net Income | 41.47B |
| EBITDA | 65.31B |
| EBIT | 74.75B |
| Earnings Per Share (EPS) | 195.83 |
Balance Sheet
The company has 230.15B in cash and 1.46B in debt, giving a net cash position of 228.7B.
| Cash & Cash Equivalents | 230.15B |
| Total Debt | 1.46B |
| Net Cash | 228.7B |
| Retained Earnings | 439.31B |
| Total Assets | 1,814.5B |
| Working Capital | 233.44B |
Cash Flow
In the last 12 months, operating cash flow was 61.84B and capital expenditures -19.39B, giving a free cash flow of 42.45B.
| Operating Cash Flow | 61.84B |
| Capital Expenditures | -19.39B |
| Free Cash Flow | 42.45B |
| FCF Per Share | 200.43 |
Margins
Gross margin is 6.93%, with operating and profit margins of 1.33% and 1.17%.
| Gross Margin | 6.93% |
| Operating Margin | 1.33% |
| Pretax Margin | 2.1% |
| Profit Margin | 1.17% |
| EBITDA Margin | 1.84% |
| EBIT Margin | 1.33% |
| FCF Margin | 1.19% |
Dividends & Yields
MAHLY pays an annual dividend of $0.35, which amounts to a dividend yield of 1.94%.
| Dividend Per Share | $0.35 |
| Dividend Yield | 1.94% |
| Dividend Growth (YoY) | 47.6% |
| Payout Ratio | 21.37% |
| Earnings Yield | 8.36% |
| FCF Yield | 8.55% |
Analyst Forecast
Currently there are no analyst rating for MAHLY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 6 |